aflibercept vs timolol
Side-by-side comparison of aflibercept and timolol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Eylea
Timoptic
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Timolol (Timoptic) eye drops help lower pressure inside the eye. It is used for people with glaucoma or high eye pressure.
AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
This medicine treats high pressure inside your eye. It is for people who have open-angle glaucoma or ocular hypertension. It works if other beta-blocker medicines haven't worked well enough to lower your eye pressure.
AHZANTIVE is a VEGF inhibitor. VEGF is a protein that promotes the growth of new blood vessels. By blocking VEGF, AHZANTIVE helps to reduce the growth of abnormal blood vessels in the eye and decrease leakage.
Timolol contains two medicines that lower eye pressure. One medicine lowers the amount of fluid your eye makes. The other medicine helps fluid drain better from your eye.
- • Bleeding in the eye
- • Eye pain
- • Clouding of the lens of the eye (cataract)
- • Separation of the vitreous gel from the retina
- • Spots in your vision
- • Bitter, sour, or unusual taste
- • Eye burning or stinging
- • Redness of the eye
- • Blurred vision
- • Eye itching
- Death 7,853
- Trouble seeing 2,013
- Using the medicine for something it's not approved for 1,509
- Loss of sight 1,459
- Eye infection 1,372
- The medicine did not work 3,042
- The medicine did not work 783
- Feeling tired 470
- Allergic reaction 456
- Feeling lightheaded 401
Injections with AHZANTIVE may cause serious eye infections (endophthalmitis), separation of the retina (retinal detachment), and inflammation of blood vessels in the retina. Tell your doctor right away if you have any signs of these problems. AHZANTIVE may also increase the risk of blood clots that can cause stroke or heart attack.
Timolol can cause serious breathing problems, including asthma. It can also cause heart failure. If you have asthma, COPD, or heart problems, talk to your doctor before using this medicine. This medicine contains a sulfonamide and can cause a severe allergic reaction. Stop using this medicine and contact your doctor immediately if you experience any signs of an allergic reaction.
It is not known if AHZANTIVE can harm an unborn baby. AHZANTIVE should be used during pregnancy only if the benefit justifies the risk. It is also not known if AHZANTIVE passes into breast milk.
Tell your doctor if you are pregnant or plan to become pregnant. This medicine should only be used during pregnancy if the benefit outweighs the risk to the baby. Timolol can pass into breast milk. Talk to your doctor about whether to stop breastfeeding or stop using this medicine.
Also Compare — Nearby Drugs
Compare aflibercept with
How to Read This aflibercept vs timolol Comparison
aflibercept is classified in the Anti-VEGF (Ophthalmic Injection) drug class, while timolol sits within the Beta-Blocker (Ophthalmic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aflibercept has 14,206 submissions while timolol has 5,152. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aflibercept and timolol — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.